If you’d like to explore the differences between ketamine therapy or Spravato (esketamine) treatment, book a complimentary consultation below. We look forward to speaking with you.

Ketamine Therapy and Spravato (Esketamine) Treatment for Depression Relief

Understanding ketamine and esketamine treatments

A short guide on Ketamine vs Esketamine from Dr. Ben Yudkoff

Thumbnail of a video essay by Dr. Ben Yudkoff, explaining the differences between ketamine, esketamine, Spravato, and their impacts on depression (treatment-resistant depression).
Explore the differences between ketamine, esketamine, and Spravato with a brief overview from Lumin Health's Chief Medical Officer and Co-Founder.

What is ketamine?

Ketamine was developed in the 1960s as an anesthetic to help people sleep before surgery. While high doses induce sleep, lower doses actually stimulate the brain. This unique effect led researchers in the late 1990s and early 2000s to explore low-dose ketamine as a novel antidepressant, given its potential to promote brain cell activity and change.

How does ketamine therapy work?

At low doses, ketamine stimulates brain cells much like exercise stimulates muscles. This leads to the release of a growth hormone called Brain-Derived Neurotrophic Factor (BDNF). BDNF encourages the growth of new connections between brain cells, known as synapses, which may be reduced in cases of treatment-resistant depression. By promoting synapse growth, ketamine and Spravato (esketamine) can help reverse some brain changes associated with depression.

These medications also affect the Default Mode Network (DMN) in the brain – a circuit involved in processing the world around us, storing personal memories, reflecting on emotions, and social interactions. In depression and other psychiatric conditions, the DMN may function differently. After ketamine or Spravato (esketamine) administration, the DMN is temporarily disrupted, potentially altering thought processes. As the medication clears from the system over several hours, research suggests the DMN returns to healthier functioning.

Additionally, ketamine interacts with opioid receptors in the brain – the same receptors that respond to endorphins and create a "runner's high" – which can elevate mood. The medicine also alters the function of a type of cell in the brain called an "astrocyte," changing the way your brain measures how feasible a task appears to be. The medicine helps the brain see possibility where it once only interpreted futility.

The therapeutic experience of ketamine and Spravato (esketamine)

Beyond biological effects, ketamine and Spravato (esketamine) can open doors to new ways of thinking and perceiving. During treatment, you may experience a sense of warmth and relaxation, with a heightened awareness of the present moment. Many people describe feeling a gentle detachment from everyday concerns, allowing for profound insights and a fresh perspective on life.

Some individuals report seeing calming patterns or colors, and sounds may become more vivid and soothing. This serene state can help you reconnect with yourself and explore positive emotions and thoughts. The experience typically lasts between 30 to 120 minutes, providing a peaceful interlude that can contribute to your healing journey.

We are dedicated to making your treatment as comfortable and uplifting as possible. Our tranquil setting is designed to support your well-being. We recommend wearing cozy clothing and bringing headphones to enjoy calming music during your session.

Ketamine vs. Spravato (esketamine)

Ketamine consists of two mirror-image molecules, similar to how your left and right hands are mirror images. Spravato (esketamine) is the left-sided oriented molecule. Differences between ketamine and esketamine are as below.

Spravato (Esketamine)

Ketamine

FDA-approval
X
Insurance coverage
Full coverage by most major plans
Parts can rarely be covered by insurance
Conditions treated
FDA-Approved for treatment-resistant depression and major depressive disorder
Off-label for depression, anxiety, ptsd, and others
Efficacy
Similar rates of response and remission
* source: https://pubmed.ncbi.nlm.nih.gov/36724113/
Administration route
Intranasal spray
Intravenous infusion, intramuscular injection, oral lozenge, or intranasal spray
  • Ketamine is typically administered intravenously or via intramuscular injection to ensure proper dosing, as it is not well-absorbed orally or through the skin.
  • Spravato (esketamine) can be absorbed through nasal tissues, allowing it to be delivered as a nasal spray. It is FDA-approved for treating depression and suicidality and is covered by most insurance plans.

Ketamine vs. Spravato (esketamine)

Ketamine consists of two mirror-image molecules, similar to how your left and right hands are mirror images. Spravato (esketamine) is one of these molecules. Due to differences in absorption:
  • Ketamine is typically administered intravenously or via intramuscular injection to ensure proper dosing, as it is not well-absorbed orally or through the skin.
  • Spravato (esketamine) can be absorbed through nasal tissues, allowing it to be delivered as a nasal spray. It is FDA-approved for treating depression and suicidality and is covered by most insurance plans.

What conditions can ketamine and esketamine treat?

Due to regulatory differences, ketamine and Spravato (esketamine) are used for various conditions:
  • Spravato (esketamine) is approved for treatment-resistant major depressive disorder and suicidality related to depression is typically administered intranasally.
  • Ketamine is used (off-label) to treat depression (from major depressive disorder or bipolar disorder), obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), and anxiety.

Ketamine treatment led by psychiatrists at Lumin Health – decades of experience, over 1,800 patients helped

The Lumin Health medical team
Our team of academically-affiliated and board-certified psychiatrists and clinicians are experts in ketamine and esketamine treatment. As specialists in esketamine (Spravato) and ketamine therapy, we provide safe, effective care with rigorous protocols and personalized treatment plans.
The Lumin Health concierge team
Our patient concierge team handles the entire process: insurance verification, scheduling, and intake. Our team would be grateful to connect to answer your questions about ketamine and Spravato. We handle the details so you can focus on getting better.
Left arrow | Lumin Health | 5.0 star insurance-covered ketamine therapy for depression, anxiety and PTSD in Boston, MA and Bethesda, MD
Right arrow | Lumin Health | 5.0 star insurance-covered ketamine therapy and esketamine (Spravato) treatment for depression, anxiety and PTSD in Boston, MA and Bethesda, MD
Benjamin Yudkoff, MD, MA
Instructor in Psychiatry at Harvard Medical School
Matthew Mosquera, MD, MS
Lecturer in Psychiatry, Harvard Medical School
Aakash Sathappan, MD
Instructor in Psychiatry; Harvard Medical School
SJ Fletcher, MD PhD
Instructor in Psychiatry; Harvard Medical School
Mona Itani MD, MS
MD, MS; Residency in Psychiatry at Tufts Medical Center; Fellowship in Addiction Psychiatry at Boston University
Kiana Fussner
Duquesne University
Hannah O'Laoghaire
Rebecca Nguyen
Office Manager
Klarissa Ramkissoon, MSN, FNP-BC
Master from Regis College
Kevin Warming
McLean Hospital
Chester Domoracki
Emily Brett, PA-C, CAQ-Psy
PA-C, CAQ-Psy
Kacey Malz, LCSW
Master’s from Boston College
Madison Chau, LCSW
Masters from Boston University
Kandace Small, RN
Bachelor's from Framingham State University
Rosie Cohen, Mental Health Counselor
Masters from Salve Regina University
Sarojini Schutt
Master’s from Brandeis University, Bachelor from Goucher College
Elizabeth Biondo, BSN, RN
BSN at Simmons University
Tessa Rockwell, RN
RN
Sahana Heiderscheidt
MBA from Boston College
Terrin Gathers, PMHNP
MSN, PMHNP
Taylor Brodersen, RN
MGH Institute of Health Professions
James "Matt" Neal, PMHNP
Jess Mahoney
Sabrina Nebiye, RN
BSN from Northeastern University
Alison Choate, RN
BSN from University of Massachusetts Amherst
Elaura Patton, PA-C, MA
Emergency Medicine at Harvard-affiliated Mass General Hospital
Jonah Shifrin
Background in Neuropsychology

Why patients and providers trust and recommend Lumin Health for ketamine therapy and esketamine (Spravato) treatment